QUARTERLY RESULTS (UNAUDITED)

12 Months Ended

Jun. 30, 2020

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information [Text Block]

QUARTERLY RESULTS (UNAUDITED)

Quarters Ended		Sep 30			Dec 31			Mar 31			Jun 30			Total Year
NET SALES	2019-2020	$	17,798		$	18,240		$	17,214		$	17,698		$	70,950
	2018-2019	16,690			17,438			16,462			17,094			67,684
OPERATING INCOME	2019-2020	4,290			4,482			3,453			3,481			15,706
	2018-2019	3,554			3,896			3,229			(5,192)			5,487
GROSS MARGIN	2019-2020	51.0		%	51.4		%	49.4		%	49.5		%	50.3		%
	2018-2019	49.2		%	48.9		%	48.8		%	47.7		%	48.6		%
NET EARNINGS/(LOSS):
Net earnings/(loss)	2019-2020	3,617			3,743			2,957			2,786			13,103
	2018-2019	3,211			3,216			2,776			(5,237)			3,966
Net earnings/(loss) attributable to Procter & Gamble	2019-2020	3,593			3,717			2,917			2,800			13,027
	2018-2019	3,199			3,194			2,745			(5,241)			3,897
DILUTED NET EARNINGS/(LOSS) PER COMMON SHARE (1) (2)	2019-2020	$	1.36		$	1.41		$	1.12		$	1.07		$	4.96
	2018-2019	1.22			1.22			1.04			(2.12)			1.43

⁽¹⁾Diluted net earnings/(loss) per share is calculated on Net earnings/(loss) attributable to Procter & Gamble.

⁽²⁾Diluted net earnings/(loss) per share in each quarter is computed using the weighted average number of shares outstanding during that quarter while Diluted net earnings/(loss) per share for the full year is computed using the weighted average number of shares outstanding during the year.  In the quarter ended June 30, 2019, the Company reported a Net loss attributable to P&G, driven by the Shave Care impairment charges discussed in Note 4.  This caused certain of our equity instruments to be antidilutive for the full year (preferred shares) and for the quarter ended June 30, 2019 (preferred shares and equity awards). Because these securities were dilutive during the first three quarters of this fiscal year, the sum of the four quarters' Diluted net earnings/(loss) per share will not equal the full-year Diluted net earnings per common share.